KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Total Current Liabilities (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Total Current Liabilities data on record, last reported at $2.6 billion in Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 5.42% year-over-year to $2.6 billion; the TTM value through Dec 2025 reached $2.6 billion, up 5.42%, while the annual FY2025 figure was $2.6 billion, 5.42% up from the prior year.
  • Total Current Liabilities reached $2.6 billion in Q4 2025 per ZBH's latest filing, up from $2.4 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $3.6 billion in Q2 2024 and bottomed at $2.1 billion in Q3 2023.
  • Average Total Current Liabilities over 5 years is $2.7 billion, with a median of $2.5 billion recorded in 2022.
  • Peak YoY movement for Total Current Liabilities: plummeted 44.72% in 2021, then surged 72.4% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $3.5 billion in 2021, then crashed by 32.0% to $2.4 billion in 2022, then grew by 21.17% to $2.9 billion in 2023, then decreased by 14.23% to $2.5 billion in 2024, then grew by 5.42% to $2.6 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $2.6 billion in Q4 2025, $2.4 billion in Q3 2025, and $2.7 billion in Q2 2025.